Welcome to our dedicated page for Sotera Health news (Ticker: SHC), a resource for investors and traders seeking the latest updates and insights on Sotera Health stock.
Sotera Health Company provides sterilization solutions, lab testing and advisory services for the healthcare industry through Sterigenics, Nordion and Nelson Labs. News about SHC commonly covers quarterly and annual operating results, constant-currency revenue trends, Adjusted EBITDA commentary and outlook updates across those businesses.
Recurring company developments also include segment performance in outsourced terminal sterilization, irradiation services and laboratory testing, as well as governance changes, board committee assignments and capital-structure activity involving its Nasdaq-listed common stock. Sterigenics uses gamma irradiation, EO processing and E-beam irradiation for medical device, pharmaceutical, food safety and other application markets.
Sotera Health Company (Nasdaq: SHC) plans to release its financial results for Q1 2022 on May 5, 2022, before market open. A conference call to discuss the results will take place at 9:00 a.m. Eastern Time. Participants can join by dialing 1-866-777-2509 from the U.S. or 1-412-317-5413 internationally. A live webcast of the call will be available on the company’s Investor Relations website, with a replay accessible later on the same day.
Sotera Health Company (Nasdaq: SHC) has launched the Sotera Health Academy, a new educational platform offering over 100 hours of curated content aimed at supporting MedTech and Pharmaceutical customers. The Academy features more than 150 resources, including webinars and eBooks, created by industry experts from Nelson Labs, Sterigenics, and Nordion. This initiative follows Sotera's acquisition of Regulatory Compliance Associates, enhancing the platform's offerings. The Academy aims to help manufacturers navigate regulatory risks and accelerate product market entry.
Sotera Health Company (Nasdaq: SHC) reported a strong financial performance for Q4 2021, with net revenues increasing by 11.3% to $241 million and a net income of $36 million, recovering from a loss of $44 million in the previous year. For the full year, revenues rose 13.9% to $931 million, with net income of $117 million compared to a loss of $39 million in 2020. The company expects 2022 revenue growth of 7% to 11% and plans significant investments in capacity expansions. Total debt stood at $1.8 billion with a net leverage ratio of 3.5x as of December 31, 2021.
Nelson Labs has launched the Nelson Labs Mark, a verification program aimed at enhancing transparency in product testing, particularly for face masks and respirators. This initiative addresses the rise of fraudulent products during the ongoing COVID-19 pandemic, providing consumers and institutions with reliable data on product performance. The program includes two-factor authentication for product verification and will expand to include other products as needed. This effort is part of Nelson Labs' mission to safeguard global health.
Sotera Health Company (Nasdaq: SHC) will announce its financial results for Q4 and full year ended December 31, 2021, on March 1, 2022, before market open. The company is a leading provider of sterilization solutions and lab testing services for healthcare. Following the announcement, a conference call will take place at 9:00 a.m. ET to discuss operating highlights and results. Interested participants can access the call via a dedicated phone line or through a live webcast on the company’s Investor Relations website.
Sotera Health Company (NASDAQ: SHC) has provided an update on its growth and achievements during the 40th Annual J.P. Morgan Healthcare Conference. The company expects its full-year 2021 revenues to reach between $920 million and $930 million, reflecting a growth of approximately 14% from the previous year. CEO Michael B. Petras, Jr. emphasized the company's strong execution throughout 2021 and shared insights on its long-term growth strategy and ESG initiatives. Full financial results for Q4 and year-end 2021 will be reported on March 1, 2022.
Sotera Health Company (NASDAQ: SHC) announced that Chairman and CEO Michael B. Petras, Jr. will present at the 40th Annual J.P. Morgan Healthcare Conference on January 11, 2022, at 7:30 am Eastern. The presentation will provide updates on the company’s diverse businesses focused on end-to-end sterilization solutions and lab testing for healthcare. The management team, including CFO Scott Leffler, will engage in one-on-one meetings with investors. A live webcast can be accessed via the company’s Investor Relations page, and a replay will be available afterward.
Sotera Health Company (Nasdaq: SHC) reported Q3 2021 net revenues of $226 million, up 13.1% from Q3 2020. Net income rose to $27 million or $0.10 per diluted share, compared to $0.01 million in Q3 2020. Adjusted EBITDA increased 16.1% to $117 million, and Adjusted EPS improved to $0.21. Total debt as of September 30, 2021, was $1.78 billion with a net leverage ratio of 3.6x. The company narrowed its full-year revenue outlook to $920 million - $930 million, reflecting 12% - 14% growth.
Sotera Health Company (Nasdaq: SHC) will release its financial results for Q3 and the first nine months of 2021 on November 10, 2021, prior to market open. A conference call will follow at 9:00 a.m. ET to discuss operational highlights and financial results. Participants from the U.S. and Canada can dial 1-833-303-1211, while international attendees can call 1-918-922-6527. A live webcast will be available on the Company’s investor relations website.
SALT LAKE CITY and OAK BROOK, Ill., September 28, 2021 – Nelson Labs and Sterigenics Germany announced an expansion of their Wiesbaden facility, enhancing microbiological laboratory testing and sterilization capacity. This expansion responds to rising demand from the medical device and pharmaceutical sectors, with the lab now ten times larger, featuring advanced testing capabilities. The upgraded facility will streamline services, reducing outsourcing needs. Sterigenics also increased sterilization capacity, reinforcing its commitment to meet customer demands swiftly and safely.